Threats and Opportunities for European Pharmaceutical Wholesalers in a Changing Healthcare Environment

1 - Table of Contents [Seite 3]
2 - Index of Figures [Seite 4]
3 - Index of Tables [Seite 5]
4 - Index of Abbreviations [Seite 6]
5 - Others [Seite 7]
6 - Executive Summary [Seite 9]
7 - 1. Introduction [Seite 12]
7.1 - 1.1 Tradition and Change [Seite 12]
7.2 - 1.2 Healthcare in Transition [Seite 13]
7.3 - 1.3 Research Objectives [Seite 17]
7.4 - 1.4 Structure [Seite 18]
7.5 - 1.5 Data Source [Seite 18]
8 - 2. Pharmaceutical Wholesale Distribution [Seite 20]
8.1 - 2.1 Pharmaceutical Supply Chain [Seite 20]
8.2 - 2.2 Full-line Pharmaceutical Wholesalers [Seite 21]
8.3 - 2.3 Short-line Pharmaceutical Wholesalers [Seite 22]
8.4 - 2.4 Functions of Pharmaceutical Wholesalers [Seite 23]
8.4.1 - 2.4.1 Bridging of Distances [Seite 24]
8.4.2 - 2.4.2 Bridging of Time [Seite 25]
8.4.3 - 2.4.3 Quantity Function [Seite 25]
8.4.4 - 2.4.4 Quality Function [Seite 27]
8.4.5 - 2.4.5 Services creating Added Value [Seite 28]
8.5 - 2.4.6 Coverage [Seite 30]
9 - 3. Healthcare in Transition [Seite 32]
9.1 - 3.1 Changing Demographic Composition [Seite 32]
9.2 - 3.2 Challenges in Healthcare Funding [Seite 36]
9.3 - 3.3 Cost-driven Changes [Seite 37]
9.3.1 - 3.3.1 Generic Market Penetration [Seite 37]
9.3.2 - 3.3.2 Price Erosion [Seite 41]
9.4 - 3.4 Structural Alterations in the Pharmaceutical Supply Chain [Seite 44]
9.4.1 - 3.4.1 Direct Deliveries [Seite 45]
9.4.2 - 3.4.2 Public Service Obligation [Seite 49]
9.4.3 - 3.4.3 Certified Supply Chain [Seite 50]
9.5 - 3.5 Transforming Healthcare Systems in CEE [Seite 52]
9.5.1 - 3.5.1 The Post-Semaskho Era [Seite 52]
9.5.2 - 3.5.2 Informal Payments and Corruption [Seite 54]
10 - 4. Sustainable Growth [Seite 58]
10.1 - 4.1 Outsourcing [Seite 58]
10.2 - 4.2 Value Added Services [Seite 61]
10.3 - 4.3 Vertical Integration [Seite 62]
10.3.1 - 4.3.1 Sweden Abolishes Pharmacy Monopoly [Seite 63]
10.3.2 - 4.3.2 Legislation [Seite 64]
10.4 - 4.4 Cooperation models [Seite 69]
10.5 - 4.5 Pharmerging Markets [Seite 72]
11 - 5. Conclusion [Seite 76]
12 - Bibliography [Seite 79]
13 - Author's Profile [Seite 85]